FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis

[1] Lund B(2011)Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia Pediatr Blood Cancer 56 551-559

[2] Asberg A(2009)Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group Leukemia 23 1264-1269

[3] Heyman M(2015)Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients Crit Rev Oncol Hematol 94 87-97

[4] Kanerva J(2005)Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001 Br J Haematol 131 50-58

[5] Harila-Saari A(2017)Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy F1000Research 6 444-2025

[6] Hasle H(2004)Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995-284

[7] Soderhall S(2004)The pathobiology of mucositis Nat Rev Cancer 4 277-2083

[8] Jonsson OG(2013)Emerging evidence on the pathobiology of mucositis Support Care Cancer 21 2075-164

[9] Lydersen S(2015)Mucositis: pathobiology and management Curr Opin Oncol 27 159-347

[10] Schmiegelow K(2017)New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury Front Pharmacol 8 354-97

[1] Lund B(2011)Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia Pediatr Blood Cancer 56 551-559

[2] Asberg A(2009)Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group Leukemia 23 1264-1269

[3] Heyman M(2015)Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients Crit Rev Oncol Hematol 94 87-97

[4] Kanerva J(2005)Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001 Br J Haematol 131 50-58

[5] Harila-Saari A(2017)Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy F1000Research 6 444-2025

[6] Hasle H(2004)Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995-284

[7] Soderhall S(2004)The pathobiology of mucositis Nat Rev Cancer 4 277-2083

[8] Jonsson OG(2013)Emerging evidence on the pathobiology of mucositis Support Care Cancer 21 2075-164

[9] Lydersen S(2015)Mucositis: pathobiology and management Curr Opin Oncol 27 159-347

[10] Schmiegelow K(2017)New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury Front Pharmacol 8 354-97